Insights on the Pharmaceutical Isolator Global Market to 2027 - Increasing Need of Sterility and Assurance of Pharmaceutical Isolators is Driving Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Isolator Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.

The Pharmaceutical Isolator Market is projected to register a CAGR of 10% during the forecast period (2022-2027).

Companies Mentioned

• Getimge AB
• Chiyoda Corporation
• Azbil Corporation
• Germfree MBRAUN
• Wabash National Corporation
• NuAire
• ITECO s.r.l
• COMECER s.p.A
• Hosokawa
• Hecht Technologie GmbH
• TEMA SINERGIE S.p.A
• Bioquell Inc.

Key Market Trends

The sudden outbreak of COVID-19 had increased the demand for biologics in order to treat the infected people and provide vaccinations. The pharmaceutical and biotechnology industries segment is expected to hold the major share in the forecast period owing to the novel drug development and protein pharmaceutical synthesis using recombinant DNA technology.

Key factors such as increasing expenditure in the research and development by the pharmaceuticals and biotechnology industries to develop protein-based therapy are expected to show a significant impact on the growth of the market. According to the data published by Organisation for Economic Co-Operation and Development (OECD) in 2020, the pharmaceutical industry spend nearly USD 101 Billion on Research and Development in the OECD countries.

Also from the same source, it is reported that global R&D spending by the largest publicly- traded companies grew 13.7% annually. Therefore, the increasing expenditure on the research and development by the pharmaceutical and biotechnology industries to develop their product pipeline is expected to boost the growth of the expression vectors market. Hence, the pharmaceutical and biotechnology industries are expected to hold a significant share in the market during the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The increase in the adoption of highly advanced techniques and systems in genomics and proteomics, novel drug discovery and development is expected to boost the growth of the market in the North American region. Also, the increasing funding from the government organizations for the research and development activities in the United States is a major contributing factor for the growth of the market in this region.

According to the data published by the National Center for Biotechnology Information (NCBI), Biotechnology funding by the National Institute of Health (NIH) was around 7.77 Billion USD during the fiscal year 2020. Also, the data published by the Federation of American scientists reported that federal funding for research and development grew 5.9% in 2020 compared to 2019, which was 138.9 billion USD. The Nation's 42 federally funded research and development centers spend around 23.5 Billion USD on research and development in the fiscal year 2020. Additionally, the presence of major market players in this region is also a major factor for the growth of the market in this region.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Need of Sterility and Assurance of Pharmaceutical Isolator

4.2.2 Low Operational Cost of Pharmaceutical Isolators

4.3 Market Restraints

4.3.1 Availability of Alternatives

4.4 Porter's Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Type

5.1.1 Closed Isolator Systems

5.1.2 Open Isolator Systems

5.2 By Application

5.2.1 Aseptic Isolators

5.2.2 Containment Isolators

5.2.3 Others

5.3 By End user

5.3.1 Pharmaceutical and Biotechnology Companies

5.3.2 Research Laboratories

5.3.3 Others

5.4 Geography

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/c1c351